Biotechnology
Urgent support needed following the pandemic's effect on cancer screening services
Dry July call to arms will improve support for cancer patients SYDNEY, July 14, 2022 /PRNewswire/ -- Dry July Foundation is urging Australians to dig even deeper this Dry July to help people affected by cancer. So many Australians could not access vital lifesaving cancer screenings and treatment...
2022-07-14 17:19
2604
Nanoform and Pharmanovia to breathe new life into iconic medicines
HELSINKI, July 14, 2022 /PRNewswire/ -- Nanoform Finland Plc., an innovative nanoparticle medicine-enabling company, today announced that it has partnered with Pharmanovia, a fast-growing specialty pharma business with a portfolio of over 20 branded drugs in 140 markets. The new strategic partne...
2022-07-14 13:55
1530
GenScript ProBio and DAAN Bio Therapeutics, Sign a Strategic Cooperation MOU for the Discovery and Development of Novel Drugs
SEOUL, South Korea, July 14, 2022 /PRNewswire/ -- On the July 14, 2022, GenScript ProBio (Brian Ho-sung Min, CEO), a global CDMO, and DAAN Bio Therapeutics (Byoung Chul Cho, Co-Founder & CEO), an innovative new drug developer such as antibody treatments and cell therapy drugs, announced that the...
2022-07-14 13:00
2105
U.S. FDA Grants Emergency Use Authorization for Novavax COVID-19 Vaccine, Adjuvanted for Individuals Aged 18 and Over
* Novavax' vaccine is the first protein-based COVID-19 vaccine authorized in the U.S. * Immunizations with the Novavax COVID-19 Vaccine, Adjuvanted as a primary series will begin upon product release and once a policy recommendation from the CDC is received GAITHERSBURG, Md., July 14, 2022 /P...
2022-07-14 06:06
2444
miR Scientific is proud to announce the commercial availability of the miR Sentinel™ Prostate Cancer Test
NEW YORK, July 14, 2022 /PRNewswire/ -- miR Scientific, LLC announces the miR Sentinel™ Prostate Cancer Test is now commercially available in the United States, Puerto Rico and select international markets. miR Sentinel™ is a novel, urine-based, molecular test that analyzes small non-coding RNA ...
2022-07-14 00:20
2107
Glenmark Pharmaceuticals and SaNOtize Announce Peer Reviewed Publication of Its Phase 3 Clinical Trials on SaNOtize's Novel Nitric Oxide Nasal Spray for COVID-19 in Lancet Journal
MUMBAI, India and VANCOUVER, BC, July 13, 2022 /PRNewswire/ -- Glenmark Pharmaceuticals Limited (Glenmark), an innovation-driven, global pharmaceutical company and SaNOtize Research and Development Corp, today announced thatThe Lancet Regional Health Southeast Asia (TLRHSEA) – peer reviewed, high...
2022-07-13 20:06
2559
Brii Biosciences Appoints Dr. Susannah Cantrell as Chief Business Officer
Strategic executive hire adds to Company's global leadership team and positions
the Company for continued growth
DURHAM, N.C.and BEIJING, July 13, 2022 /PRNewswire/ -- Brii Biosciences
Limited
2022-07-13 19:00
2227
Subang Jaya Medical Centre Applauded by Frost & Sullivan for Its Leadership Position in the Malaysian Hospital Industry
SJMC is well positioned to drive the private hospital space into its next growth phase, capturing market share and sustaining its leadership in the coming years. SAN ANTONIO, July 13, 2022 /PRNewswire/ -- Recently, Frost & Sullivan researched the Malaysian hospital industry and, based on its ana...
2022-07-13 12:12
1830
GenScript ProBio Signs MOU to Form Strategic Partnership with ACT Therapeutics to Development of New CAR-T Cell Therapies
SEOUL, South Korea, July 12, 2022 /PRNewswire/ -- On the July 12, 2022, GenScript ProBio (Brian Ho-sung Min, CEO), a global CDMO, and ACT Therapeutics (Seogkyoung-Kong, CEO), developing next-generation chimeric antigen receptor (CAR)-T cell therapy platform targeting solid cancer, announced that ...
2022-07-13 08:00
2559
Amaran Biotech Introduces the First Fully-Automated Robotic Aseptic Filling Line in Taiwan During Bio Asia-Taiwan 2022 7/28-7/31
HSINCHU, July 13, 2022 /PRNewswire/ -- Amaran Biotechnology Inc., a subsidiary ofTaiwan's OBI Pharma Inc., today announced that the construction of its fully-automated aseptic filling line and facilities, a first inTaiwan, has been completed. The new facility minimizes the risks of human factors ...
2022-07-13 08:00
3474
Discovery Life Sciences Acquires AllCells
CREATES PREMIER GLOBAL PROVIDER OF CRITICAL STARTING MATERIALS AND ANALYTIC SERVICES TO ACCELERATE CELL AND GENE THERAPY APPLICATIONS HUNTSVILLE, Ala. and ALAMEDA, Calif., July 12, 2022 /PRNewswire/ -- Discovery Life Sciences™ (Discovery), the biospecimen and biomarker specialists™, today announ...
2022-07-12 21:00
2889
Biomerics Launches Interventional Medical Plastics Division with Acquisition of Dependable Plastics
SALT LAKE CITY, July 11, 2022 /PRNewswire/ -- Biomerics, the leading vertically integrated medical device contract manufacturer in the interventional device market, announced the acquisition of Dependable Plastics and creation of a new division -- Biomerics Interventional Medical Plastics (IMP) D...
2022-07-11 22:00
2157
U.S. Government Secures 3.2 Million Doses of Novavax COVID-19 Vaccine
* Agreement will provide the first protein-based vaccine option in the U.S., pending FDA Emergency Use Authorization and CDC recommendation GAITHERSBURG, Md. ,July 11, 2022 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-gene...
2022-07-11 20:10
2844
SCG Cell Therapy Announces U.S FDA Clearance of Investigational New Drug Application for SCG101, SCG's Novel TCR-T Cell Therapy For Hepatitis B-related Liver Cancers
SINGAPORE, July 11, 2022 /PRNewswire/ -- Singapore-based SCG Cell Therapy Pte Ltd ("SCG") announced that U.S. Food and Drug Administration (FDA) has cleared the Investigational New Drug (IND) application for SCG101, an investigational T-cell receptor (TCR) T cell therapy for patients with hepati...
2022-07-11 13:34
2254
Kevin Richardson appointed as CEO, Telix Americas
MELBOURNE and INDIANAPOLIS, July 11, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) is pleased to announce thatKevin Richardson, a senior global executive with a career focus on sales, marketing and business operations in the oncology and radiopharmaceutical mar...
2022-07-11 08:13
2289
Meridian Bioscience, Inc. Enters into Agreement to Be Acquired by SD Biosensor and SJL Partners in $1.53 Billion All-Cash Transaction
Shareholders to Receive $34.00 Per Share in Cash, Providing Immediate, Compelling and Certain Value Transaction Follows Deliberate Review, Including Outreach to Potential Strategic and Financial Partners CINCINNATI and SEOUL, South Korea, July 8, 2022 /PRNewswire/ -- Meridian Bioscience, Inc. (...
2022-07-08 08:41
4946
Billion-Euro Market Biotechnology: Exyte Builds mRNA Competence Center for WACKER in Halle
* Exyte named as general contractor (EPCQ contract partner) * Project is part of the German government's program to prepare for future pandemics * Implementation in less than 24 months thanks to ExyCell® modular system * Lighthouse project for the strategic growth segment of Biopharma and L...
2022-07-08 06:58
4052
HaemaLogiX strengthens Board with appointment of Dr. Geoff Nichol
* Dr. Geoff Nichol, M.B., Ch.B., M.B.A., joins HaemaLogiX's Board of Directors as Non-Executive Director, bringing nearly 30 years of global drug development experience * Past achievements include approval of Augmentin BID for adults and children, plus foundational clinical development of bre...
2022-07-08 05:30
2453
Deep Longevity Published and Granted the First Microbiomic Aging Clock Patent
HONG KONG, July 7, 2022 /PRNewswire/ -- Endurance RP Limited's ("Endurance Longevity" or the "Company" and together with its subsidiaries, the "Group"; stock code: 0575.HK) wholly owned subsidiaryDeep Longevity, Inc, a Hong Kong -based AI innovator and a leading provider of deep biomarkers of agin...
2022-07-07 12:18
4152
Brii Biosciences Announces Commercial Launch of its Amubarvimab/Romlusevimab Combination Therapy for COVID-19 in China
The Company is working closely with its commercial partners to supply the combination therapy to patients in need Brii Bio progressed the combination therapy from discovery to global Phase 3 data readout and first regulatory approval by the China NMPA in less than 20 months, validating the Com...
2022-07-07 07:10
3366
Week's Top Stories
Most Reposted
Protiviti Transforms Cyber Risk Consulting with CYFIRMA's Advanced Intelligence-Led Cybersecurity
[Picked up by 324 media titles]
2024-04-15 09:00Sephora appoints Xia Ding as Managing Director of Sephora Greater China
[Picked up by 309 media titles]
2024-04-15 17:33
With unique features, Hainan TV opened "The World's Specialty" pavilion at the Expo!
[Picked up by 282 media titles]
2024-04-18 21:26
Animated Life in Yunnan
[Picked up by 278 media titles]
2024-04-18 14:00
China's Yiwu Establishes Welcoming Committee to Attract International Buyers
[Picked up by 277 media titles]
2024-04-19 13:25
Most Read
Sephora appoints Xia Ding as Managing Director of Sephora Greater China
2024-04-15 17:33
3819
Combining Sustainability and Cybersecurity: Century Iron & Steel and Century Wind Power Both Receive ISO 27001 Information Security Certification
2024-04-19 18:03
3618
Allianz Partners Introduces Instant Online Chat for HCF Travel Insurance Customers
2024-04-15 08:00
3085
Goldpac Exhibits at InnoEx 2024
2024-04-13 10:00
3023